Intercure annual operating cash flow
2019
2020
2021
2022
2023
2024
2025
Intercure Operating Cash Flow Growth & History (INCR)
Intercure's operating cash flow was ₪16.8M for fiscal 2025.
View full Intercure company overviewIntercure annual operating cash flow history
| Fiscal year | Period ended | Operating cash flow | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | ₪16.8M | ₪83.8M | — |
| 2024 | 2024-12-31 | −₪66.9M | −₪13.3M | — |
| 2023 | 2023-12-31 | −₪53.6M | −₪104.9M | — |
| 2022 | 2022-12-31 | ₪51.3M | ₪21.1M | +70.12% |
| 2021 | 2021-12-31 | ₪30.1M | ₪22.2M | +281.65% |
| 2020 | 2020-12-31 | ₪7.9M | ₪19.5M | — |
| 2019 | 2019-12-31 | −₪11.6M | — | — |
Intercure operating cash flow trends
Over the last five fiscal years, Intercure's operating cash flow increased from ₪7.9M to ₪16.8M, a change of ₪8.9M.
About the metric
What operating cash flow means
Operating cash flow is the cash generated or used by a company’s core operations. It incorporates working-capital movements and other operating cash items, and it is the starting point for calculating free cash flow.
Calculation and source
SEC-reported operating cash flow
TickerStat standardizes net cash provided by or used in operating activities reported in company SEC filings. It is historical filing data before capital expenditures, financing activities, and investing activities. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Intercure source filings ↗Community posts
InterCure resolves Nasdaq minimum-bid-price deficiency
InterCure ($INCR) received written confirmation that it has regained compliance with Nasdaq’s minimum-bid-price requirement. Its shares had closed at or above $1 for ten consecutive business days, allowing Nasdaq to close the specific defic ...